Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Molecular Models02:00

Molecular Models

43.7K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
43.7K
The Bohr Model02:18

The Bohr Model

80.9K
Following the work of Ernest Rutherford and his colleagues in the early twentieth century, the picture of atoms consisting of tiny dense nuclei surrounded by lighter and even tinier electrons continually moving about the nucleus was well established. This picture was called the planetary model since it pictured the atom as a miniature “solar system” with the electrons orbiting the nucleus like planets orbiting the sun. The simplest atom is hydrogen, consisting of a single proton as the...
80.9K
Stereotype Content Model02:16

Stereotype Content Model

15.4K
The Stereotype Content Model (SCM) was first proposed by Susan Fiske and her colleagues (Fiske, Cuddy, Glick & Xu, 2002; see also Fiske, 2012 and Fiske, 2017). The SCM specifies that when someone encounters a new group, they will stereotype them based on two metrics: warmth—or that group’s perceived intent, and how likely they are to provide help or inflict harm—and competence—or their ability to carry out that objective. Depending on the warmth-competence...
15.4K
Compartment Models: Two-Compartment Model01:20

Compartment Models: Two-Compartment Model

7.1K
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
7.1K
Clearance Models: Physiological Models01:09

Clearance Models: Physiological Models

317
Drug clearance is a critical pharmacokinetic process involving the irreversible removal of drugs from the body through various organs over a specified time period. Physiological models are indispensable in determining organ-specific clearance, defined by the proportion of the drug eliminated per unit of time from the organ's blood volume.
The organ's clearance rate depends on the blood flow to the organ and the extraction ratio (E). The extraction ratio describes the organ's...
317
Clearance Models: Compartment Models01:25

Clearance Models: Compartment Models

314
Clearance measures drug elimination from the central compartment, including plasma and highly perfused organs like kidneys and liver. Its calculation varies depending on pharmacokinetic models and administration routes. The one-compartment model, for instance, portrays the pharmacokinetics of polar drugs such as aminoglycoside antibiotics administered intravenously and readily excreted in urine. In this case, clearance is influenced by the terminal rate constant (λz) and the total volume...
314

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Neutrophil Extracellular Traps on Clinical Outcome after Subarachnoid Hemorrhage: A Translational Narrative Review.

Translational stroke research·2026
Same author

Biomarkers of Cardioembolic Stroke in Thrombus Composition: Diagnostic Value of DNA and Fibrin Content.

European journal of neurology·2026
Same author

[Thromboinflammation in ischemic stroke: towards new therapeutic opportunities?]

Medecine sciences : M/S·2026
Same author

Platelets in Intracranial Aneurysm: The Missing Actors in the Drama?

Arteriosclerosis, thrombosis, and vascular biology·2026
Same author

Platelet protease nexin-1 limits fibrinolysis in patients with cirrhosis.

JHEP reports : innovation in hepatology·2025
Same author

Neutrophil extracellular traps-targeting therapy with deoxyribonuclease 1 reduces large vessel occlusion-induced downstream microvascular thromboinflammation in a rat model of stroke.

Research and practice in thrombosis and haemostasis·2025

Related Experiment Video

Updated: Feb 3, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

22.4K

Microfluidic Modeling of Thrombolysis.

Stéphane Loyau1, Benoit Ho-Tin-Noé1, Marie-Charlotte Bourrienne2

  • 1From the INSERM, University Paris Diderot (S.L., B.H.-T.-N., Y.B., M.J.-P.), U1148, Laboratory for Vascular Translational Science, Paris, France.

Arteriosclerosis, Thrombosis, and Vascular Biology
|October 26, 2018
PubMed
Summary
This summary is machine-generated.

A new microfluidic model allows studying thrombolysis in human blood. It shows that platelets continue to accumulate during fibrinolysis, potentially hindering blood clot removal with recombinant tissue-type plasminogen activator (r-tPA).

Keywords:
blood plateletsfibrinfibrinolysismicrofluidicsplasminogen

More Related Videos

Studies of Bacterial Chemotaxis Using Microfluidics - Interview
10:35

Studies of Bacterial Chemotaxis Using Microfluidics - Interview

Published on: May 28, 2007

8.7K
Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
06:16

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Published on: April 19, 2024

1.8K

Related Experiment Videos

Last Updated: Feb 3, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

22.4K
Studies of Bacterial Chemotaxis Using Microfluidics - Interview
10:35

Studies of Bacterial Chemotaxis Using Microfluidics - Interview

Published on: May 28, 2007

8.7K
Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
06:16

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Published on: April 19, 2024

1.8K

Area of Science:

  • Biomedical Engineering
  • Hematology
  • Cardiovascular Research

Background:

  • Thrombolysis is clinically vital but lacks effective study models in human blood.
  • Developing a reliable model is crucial for evaluating thrombolytic therapies.

Purpose of the Study:

  • To create a microfluidic model for comparative analysis of thrombolytic strategies.
  • To investigate thrombus formation and lysis dynamics in real-time under varying flow conditions.

Main Methods:

  • Human blood was perfused in microfluidic chambers coated with collagen and tissue factor to form fluorescent thrombi.
  • Thrombi were treated with recombinant tissue-type plasminogen activator (r-tPA) and other agents, with fibrin and platelet dynamics monitored via fluorescence microscopy.
  • Fibrinolysis was confirmed by D-dimer measurements, and platelet recruitment was assessed using antiplatelet agents.

Main Results:

  • The microfluidic model successfully generated and allowed real-time monitoring of thrombus formation and lysis.
  • r-tPA demonstrated concentration-dependent reduction in thrombus fibrin content.
  • Platelet accumulation within the thrombus was observed even during active fibrinolysis, and this was inhibited by antiplatelet agents.

Conclusions:

  • The developed microfluidic model is effective for studying thrombolysis and assessing combination therapies with r-tPA.
  • Continuous platelet recruitment during r-tPA-mediated fibrinolysis may impede recanalization.
  • This model provides a platform for advancing thrombolytic research and drug development.